课题基金 / 基金详情

项目摘要

项目成果

K ALLEN GREINER的其他基金

相似基金

相关文献

中文摘要
翻译
摘要/概要 这一多样性补充的候选人是威廉托德摩尔,MPS,目前在项目主任 堪萨斯大学医学中心(KUMC)家庭医学系。摩尔先生是 堪萨斯大学的博士预科生。摩尔的长期职业目标是成为一名 独立资助的研究人员专注于癌症控制,人口健康和健康之间的差距 代表性不足的人群。摩尔先生将接受学术培训、指导研究和职业生涯 发展培训,通过这种补充,这将有助于他实现这一长期目标。 本补充材料的目标是让摩尔先生:1)接受概念化培训, 行为干预研究的实施和分析2)增加他与社会和 影响代表性不足的少数民族(URM)患者癌症相关结局的环境因素 和社区卫生工作者(CHW),以及3)建立学术出版物和赠款的跟踪记录 需要启动一个独立的研究计划,在癌症相关的健康差距。他将完成 在艾伦格雷纳博士的指导下,这些研究目标在父R 01上,在子R 01上领先, 项目包含在父母补助金的范围内,完成正式课程和研讨会,以及 出席全国会议,以建立他的技能和研究网络。该多样性补充将 为摩尔先生提供必要的培训,使他能够过渡到未来的博士后工作, 最终成为一名成功的研究人员,可以连接行为科学,CBPR和临床试验 代表性不足的少数民族(Underrepresented Minority,URM)拟议研究的结果将提高先生。 摩尔的能力,从事更多的URM在癌症临床试验研究,提高他的能力,以提高认识, 少数群体中的癌症,并直接制定干预措施,以减少这方面的癌症差异, 人口继续增长和老龄化。 具体目标1:为社区工作者制定和提供具有文化敏感性和语言适当性的干预措施 在安全网诊所与拒绝入组母R 01的筛选合格患者一起分娩 研究,但谁需要额外的关注,以促进CRC筛查。 具体目标2:开发一种对社区卫生工作者的干预措施,使他们也能促进癌症研究, 安全网诊所患者对机构高度不信任,对研究持负面看法。
英文摘要
Abstract/Summary The candidate for this diversity supplement is William Todd Moore, MPS, currently a project director in the Department of Family Medicine at the University of Kansas Medical Center (KUMC). Mr. Moore is a predoctoral student at the University of Kansas. Mr. Moore's long-term career goal is to become an independently-funded researcher focused on cancer control, population health and health disparities among underrepresented populations. Mr. Moore will receive academic training, mentored research and career development training through this supplement that will assist him in achieving this long-term goal. The goals of this supplement are for Mr. Moore to: 1) receive training in the conceptualization, implementation, and analysis of behavioral intervention studies 2) increase his knowledge related to social and environmental factors impacting cancer-related outcomes among underrepresented minority (URM) patients and community health workers (CHW), and 3) establish a track record of scholarly publications and grants needed to launch an independent research program in cancer related health disparities. He will accomplish these research goals under the mentorship of Dr. Allen Greiner on the parent R01, taking the lead on a sub- project contained within the scope of the parent grant, completing formal courses and seminars, and presenting at national conferences to build his skills and research network. This Diversity Supplement will provide Mr. Moore with the training necessary for him to transition into future postdoctoral work and an eventual role as a successful researcher that can bridge behavioral sciences, CBPR, and clinical trials research to underrepresented minority (URM) populations. Findings from the proposed study will enhance Mr. Moore's ability to engage more URMs in cancer clinical trials research, boost his ability to raise awareness of cancer among minorities, and direct development of interventions to reduce cancer disparities in this population as it continues to grow and age demographically. Specific Aim 1: To develop and deliver a culturally sensitivity and language appropriate intervention for CHWs to deliver with screening eligible patients at safety net clinics who have declined enrollment in the parent R01 study but who need additional attention to facilitate CRC screening. Specific Aim 2: To develop an intervention with CHWs that allows them to also promote cancer research to safety-net clinic patients with high levels of institutional distrust and negative opinions of research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
KanSurvive: Testing a model for improving cancer survivorship care in rural practice
KanSurvive: Testing a model for improving cancer survivorship care in rural practice
KanSurvive: Testing a model for improving cancer survivorship care in rural practice
KanSurvive: Testing a model for improving cancer survivorship care in rural practice
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
  • 批准号:
    82505677
  • 项目类别:
    青年科学基金项目(C类)
  • 资助金额:
    30.00万元
  • 批准年份:
    2025
  • 负责人:
    吕雨霏
  • 依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
  • 批准号:
    82574874
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2025
  • 负责人:
    刘天华
  • 依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位: